Search results for: 'Preferred Destination for Early Phase Clinical Trials'

The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...

Vital signs monitoring devices that support remote monitoring are growing rapidly due to the increasing need for home care and chronic disease management solutions. Moreover, the increasing workload on clinicians and nurses is driving demand for continuous vital signs monitoring solutions in hospital settings. Clinical-grade wearables are dominatin...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...

A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications. These biomarkers provide continuous, real-time insights into an individual’s health status and are used to monitor normal ...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, digital health and diagnostics industry. The issue includes advanced medical devices such as surgical robot, teleoperated robotic surgical system, autonomous navigation robot, endoscopic b...

This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...

The adoption of hemodynamic monitoring systems is growing in hospitals, driven by the development of advanced sensors for minimally invasive and noninvasive monitoring. Advancements in wearable and remote monitoring technologies are forecast to support adoption in out-of-hospital settings in the next decade. Vendors are increasingly investing in de...

The global care assistance and automation robots market is expected to achieve rapid adoption with a CAGR of 36% through 2021. As doctors and care providers pay more attention to patients, leaving daily tasks for the efficient handling of robotic systems, patients will receive improved quality of care and reduced hospital readmission, the prime rea...

07 Feb 2020  |  Asia Pacific  |  Market Research

Malaysian Diabetes Devices Market, Forecast to 2023

Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market

Infographics

×

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...